HIV-1-Specific Interleukin-21 <sup>+</sup> CD4 <sup>+</sup> T Cell Responses Contribute to Durable Viral Control through the Modulation of HIV-Specific CD8 <sup>+</sup> T Cell Function

Mathieu F. Chevalier(Harvard University), Boris Jülg(Harvard University), Augustine Pyo(Harvard University), Michael Flanders(Harvard University), Srinika Ranasinghe(Harvard University), Damien Z. Soghoian(Harvard University), Douglas S. Kwon(Harvard University), Jenna Rychert(Massachusetts General Hospital), Jeffrey Lian(Harvard University), Matthias Müller(Harvard University), Sam Cutler(Harvard University), Elizabeth McAndrew(Harvard University), Heiko Jessen, Florencia Pereyra(Harvard University), Eric Rosenberg(Massachusetts General Hospital), Marcus Altfeld(Harvard University), Bruce D. Walker(Howard Hughes Medical Institute), Hendrik Streeck(Harvard University)
Journal of Virology
November 4, 2010
Cited by 183Open Access
Full Text

Abstract

Functional defects in cytotoxic CD8(+) T cell responses arise in chronic human viral infections, but the mechanisms involved are not well understood. In mice, CD4 cell-mediated interleukin-21 (IL-21) production is necessary for the maintenance of CD8(+) T cell function and control of persistent viral infections. To investigate the potential role of IL-21 in a chronic human viral infection, we studied the rare subset of HIV-1 controllers, who are able to spontaneously control HIV-1 replication without treatment. HIV-specific triggering of IL-21 by CD4(+) T cells was significantly enriched in these persons (P = 0.0007), while isolated loss of IL-21-secreting CD4(+) T cells was characteristic for subjects with persistent viremia and progressive disease. IL-21 responses were mediated by recognition of discrete epitopes largely in the Gag protein, and expansion of IL-21(+) CD4(+) T cells in acute infection resulted in lower viral set points (P = 0.002). Moreover, IL-21 production by CD4(+) T cells of HIV controllers enhanced perforin production by HIV-1-specific CD8(+) T cells from chronic progressors even in late stages of disease, and HIV-1-specific effector CD8(+) T cells showed an enhanced ability to efficiently inhibit viral replication in vitro after IL-21 binding. These data suggest that HIV-1-specific IL-21(+) CD4(+) T cell responses might contribute to the control of viral replication in humans and are likely to be of great importance for vaccine design.


Related Papers